Participants receiving 2.4 mg of Sema weekly, alongside lifestyle modifications, experienced an average 14.9% reduction in body weight over 68 weekssubstantially more than the placebo group
This goes beyond just prescribing medication we provide comprehensive support that addresses all aspects of weight management
So I think we have injury rates, we have educational components for our patients, and then we have basic guidelines on what we can do for evaluation and treatment for our patients
Studies show that patients on Tirzepatide (Zepbound) lost approximately 20% of their body weight over 72 weeks, whereas those on semaglutide (Wegovy) lost about 14% in the same timeframe
All samples passed the quality control of OD260/OD280 between 1.7 and 2.0, concentration greater than 10 ng/l
In 2014, TGA ranked fourth of the six major NRAs in terms of New Active Substances median time to approval, based on 20042013 data